Tropic Biosciences
PrivateLast Round
Series C
Extension
Mar 12, 2026
Est. Valuation
$875M
Total Funding Raised
$179.9M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Tropic Biosciences operates in Healthcare & Life Sciences and is based in Norwich. Its latest recorded funding round was a Series C Extension round in March 2026.
Tropic Biosciences is an agricultural biotechnology company that develops high-performing commercial varieties of tropical crops like bananas, coffee, and rice using gene-editing technologies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tropic Biosciences Comparables
Compare Tropic Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pairwise | 84% | |
| Ohalo Genetics | 78% | |
| Inari | 77% |
For institutional investors. Book with your work email.
Tropic Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Mar 12, 2026 | ||||
| Series C | Jul 6, 2022 | ||||
| Series B | Jun 3, 2020 | ||||
| Series A | Jun 13, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tropic Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agronomics Limited | Series B |
| Just Climate | Series C Extension |
| DisruptAD | Series C |
| Temasek | Series C Extension, Series B |
| Bits x Bites | Series B, Series A |
| Future Planet Capital Regional | Series B |
| Forbion | Series C Extension |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 47% MoM, reaching 8.5K.
- Mar 12, 2026
$105M round completed.
For institutional investors. Book with your work email.
Tropic Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tropic Biosciences's valuation, stock price, and market status.
Is Tropic Biosciences a public or private company?
Tropic Biosciences is a private company.
What is the current stock price of Tropic Biosciences?
Tropic Biosciences is a private company, so its shares have no public market price. Caplight tracks Tropic Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tropic Biosciences worth (valuation)?
Tropic Biosciences's valuation is estimated at $875.0M based on funding round data.
Can I buy Tropic Biosciences stock?
Tropic Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tropic Biosciences's last funding round?
Tropic Biosciences's most recent funding round was Series C Extension on March 12, 2026.
Who are the main investors in Tropic Biosciences?
Key investors in Tropic Biosciences include DisruptAD, Temasek, Forbion, Blue Horizon, Aliment Capital.
Will Tropic Biosciences IPO soon?
No public IPO plans have been announced for Tropic Biosciences.
How can I track Tropic Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Tropic Biosciences's shares on secondary markets.